A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation
Display Omitted
Gespeichert in:
| Autor*in: |
Li, Qian [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:471 ; year:2014 ; number:1 ; day:25 ; month:08 ; pages:412-420 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijpharm.2014.05.065 |
|---|
| Katalog-ID: |
ELV02273550X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV02273550X | ||
| 003 | DE-627 | ||
| 005 | 20230623164640.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2014.05.065 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014012000004.pica |
| 035 | |a (DE-627)ELV02273550X | ||
| 035 | |a (ELSEVIER)S0378-5173(14)00418-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.61 |2 bkl | ||
| 100 | 1 | |a Li, Qian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation |
| 264 | 1 | |c 2014 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Trifluoroacetic acid-d (PubChem CID 71502) |2 Elsevier | |
| 650 | 7 | |a Doxorubicin (PubChem CID: 443939) |2 Elsevier | |
| 650 | 7 | |a Diisopropylcarbodiimide (PubChem CID 12734) |2 Elsevier | |
| 650 | 7 | |a Dimethylsulfoxide-D6 (PubChem CID 75151) |2 Elsevier | |
| 650 | 7 | |a Glutamic acid (PubChem CID 33032) |2 Elsevier | |
| 650 | 7 | |a N,N′-Dimethylformamide (PubChem CID 6228) |2 Elsevier | |
| 650 | 7 | |a Paclitaxel (PubChem CID: 441276) |2 Elsevier | |
| 650 | 7 | |a 4-Dimethylaminopyridine (PubChem CID 14284) |2 Elsevier | |
| 650 | 7 | |a Fluorescein isothiocyanate (PubChem CID 18730) |2 Elsevier | |
| 700 | 1 | |a Lv, Shixian |4 oth | |
| 700 | 1 | |a Tang, Zhaohui |4 oth | |
| 700 | 1 | |a Liu, Muhua |4 oth | |
| 700 | 1 | |a Zhang, Dawei |4 oth | |
| 700 | 1 | |a Yang, Yan |4 oth | |
| 700 | 1 | |a Chen, Xuesi |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
| 773 | 1 | 8 | |g volume:471 |g year:2014 |g number:1 |g day:25 |g month:08 |g pages:412-420 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2014.05.065 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 471 |j 2014 |e 1 |b 25 |c 0825 |h 412-420 |g 9 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
q l ql |
|---|---|
| matchkey_str |
liqianlvshixiantangzhaohuiliumuhuazhangd:2014----:cdlvrssebsdnaltxlrfemebllaewtdxrbcnrprt |
| hierarchy_sort_str |
2014 |
| bklnumber |
44.61 |
| publishDate |
2014 |
| allfields |
10.1016/j.ijpharm.2014.05.065 doi GBVA2014012000004.pica (DE-627)ELV02273550X (ELSEVIER)S0378-5173(14)00418-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Li, Qian verfasserin aut A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) Elsevier Lv, Shixian oth Tang, Zhaohui oth Liu, Muhua oth Zhang, Dawei oth Yang, Yan oth Chen, Xuesi oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:412-420 extent:9 https://doi.org/10.1016/j.ijpharm.2014.05.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 412-420 9 045F 610 |
| spelling |
10.1016/j.ijpharm.2014.05.065 doi GBVA2014012000004.pica (DE-627)ELV02273550X (ELSEVIER)S0378-5173(14)00418-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Li, Qian verfasserin aut A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) Elsevier Lv, Shixian oth Tang, Zhaohui oth Liu, Muhua oth Zhang, Dawei oth Yang, Yan oth Chen, Xuesi oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:412-420 extent:9 https://doi.org/10.1016/j.ijpharm.2014.05.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 412-420 9 045F 610 |
| allfields_unstemmed |
10.1016/j.ijpharm.2014.05.065 doi GBVA2014012000004.pica (DE-627)ELV02273550X (ELSEVIER)S0378-5173(14)00418-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Li, Qian verfasserin aut A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) Elsevier Lv, Shixian oth Tang, Zhaohui oth Liu, Muhua oth Zhang, Dawei oth Yang, Yan oth Chen, Xuesi oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:412-420 extent:9 https://doi.org/10.1016/j.ijpharm.2014.05.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 412-420 9 045F 610 |
| allfieldsGer |
10.1016/j.ijpharm.2014.05.065 doi GBVA2014012000004.pica (DE-627)ELV02273550X (ELSEVIER)S0378-5173(14)00418-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Li, Qian verfasserin aut A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) Elsevier Lv, Shixian oth Tang, Zhaohui oth Liu, Muhua oth Zhang, Dawei oth Yang, Yan oth Chen, Xuesi oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:412-420 extent:9 https://doi.org/10.1016/j.ijpharm.2014.05.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 412-420 9 045F 610 |
| allfieldsSound |
10.1016/j.ijpharm.2014.05.065 doi GBVA2014012000004.pica (DE-627)ELV02273550X (ELSEVIER)S0378-5173(14)00418-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Li, Qian verfasserin aut A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation 2014 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) Elsevier Lv, Shixian oth Tang, Zhaohui oth Liu, Muhua oth Zhang, Dawei oth Yang, Yan oth Chen, Xuesi oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:412-420 extent:9 https://doi.org/10.1016/j.ijpharm.2014.05.065 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 412-420 9 045F 610 |
| language |
English |
| source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:471 year:2014 number:1 day:25 month:08 pages:412-420 extent:9 |
| sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:471 year:2014 number:1 day:25 month:08 pages:412-420 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Innere Medizin |
| institution |
findex.gbv.de |
| topic_facet |
Trifluoroacetic acid-d (PubChem CID 71502) Doxorubicin (PubChem CID: 443939) Diisopropylcarbodiimide (PubChem CID 12734) Dimethylsulfoxide-D6 (PubChem CID 75151) Glutamic acid (PubChem CID 33032) N,N′-Dimethylformamide (PubChem CID 6228) Paclitaxel (PubChem CID: 441276) 4-Dimethylaminopyridine (PubChem CID 14284) Fluorescein isothiocyanate (PubChem CID 18730) |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| authorswithroles_txt_mv |
Li, Qian @@aut@@ Lv, Shixian @@oth@@ Tang, Zhaohui @@oth@@ Liu, Muhua @@oth@@ Zhang, Dawei @@oth@@ Yang, Yan @@oth@@ Chen, Xuesi @@oth@@ |
| publishDateDaySort_date |
2014-01-25T00:00:00Z |
| hierarchy_top_id |
ELV008932840 |
| dewey-sort |
3610 |
| id |
ELV02273550X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02273550X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623164640.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2014.05.065</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014012000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02273550X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(14)00418-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Li, Qian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Trifluoroacetic acid-d (PubChem CID 71502)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Doxorubicin (PubChem CID: 443939)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diisopropylcarbodiimide (PubChem CID 12734)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dimethylsulfoxide-D6 (PubChem CID 75151)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glutamic acid (PubChem CID 33032)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">N,N′-Dimethylformamide (PubChem CID 6228)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Paclitaxel (PubChem CID: 441276)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">4-Dimethylaminopyridine (PubChem CID 14284)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fluorescein isothiocyanate (PubChem CID 18730)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lv, Shixian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tang, Zhaohui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Muhua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Dawei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Yan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Xuesi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:471</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">day:25</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:412-420</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2014.05.065</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">471</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="b">25</subfield><subfield code="c">0825</subfield><subfield code="h">412-420</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Li, Qian |
| spellingShingle |
Li, Qian ddc 610 bkl 44.61 Elsevier Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation |
| authorStr |
Li, Qian |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.61 bkl A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) Elsevier |
| topic |
ddc 610 bkl 44.61 Elsevier Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) |
| topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) |
| topic_browse |
ddc 610 bkl 44.61 Elsevier Trifluoroacetic acid-d (PubChem CID 71502) Elsevier Doxorubicin (PubChem CID: 443939) Elsevier Diisopropylcarbodiimide (PubChem CID 12734) Elsevier Dimethylsulfoxide-D6 (PubChem CID 75151) Elsevier Glutamic acid (PubChem CID 33032) Elsevier N,N′-Dimethylformamide (PubChem CID 6228) Elsevier Paclitaxel (PubChem CID: 441276) Elsevier 4-Dimethylaminopyridine (PubChem CID 14284) Elsevier Fluorescein isothiocyanate (PubChem CID 18730) |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s l sl z t zt m l ml d z dz y y yy x c xc |
| hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| hierarchy_parent_id |
ELV008932840 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008932840 |
| title |
A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation |
| ctrlnum |
(DE-627)ELV02273550X (ELSEVIER)S0378-5173(14)00418-9 |
| title_full |
A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation |
| author_sort |
Li, Qian |
| journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
412 |
| author_browse |
Li, Qian |
| container_volume |
471 |
| physical |
9 |
| class |
610 610 DE-600 610 VZ 44.61 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Li, Qian |
| doi_str_mv |
10.1016/j.ijpharm.2014.05.065 |
| dewey-full |
610 |
| title_sort |
a co-delivery system based on paclitaxel grafted mpeg-b-plg loaded with doxorubicin: preparation, in vitro and in vivo evaluation |
| title_auth |
A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
1 |
| title_short |
A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation |
| url |
https://doi.org/10.1016/j.ijpharm.2014.05.065 |
| remote_bool |
true |
| author2 |
Lv, Shixian Tang, Zhaohui Liu, Muhua Zhang, Dawei Yang, Yan Chen, Xuesi |
| author2Str |
Lv, Shixian Tang, Zhaohui Liu, Muhua Zhang, Dawei Yang, Yan Chen, Xuesi |
| ppnlink |
ELV008932840 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijpharm.2014.05.065 |
| up_date |
2024-07-06T17:02:02.310Z |
| _version_ |
1803849902127579136 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02273550X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623164640.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2014.05.065</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014012000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02273550X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(14)00418-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Li, Qian</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: Preparation, in vitro and in vivo evaluation</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Trifluoroacetic acid-d (PubChem CID 71502)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Doxorubicin (PubChem CID: 443939)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diisopropylcarbodiimide (PubChem CID 12734)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dimethylsulfoxide-D6 (PubChem CID 75151)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glutamic acid (PubChem CID 33032)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">N,N′-Dimethylformamide (PubChem CID 6228)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Paclitaxel (PubChem CID: 441276)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">4-Dimethylaminopyridine (PubChem CID 14284)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fluorescein isothiocyanate (PubChem CID 18730)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lv, Shixian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tang, Zhaohui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Muhua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Dawei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yang, Yan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chen, Xuesi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:471</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">day:25</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:412-420</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2014.05.065</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">471</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="b">25</subfield><subfield code="c">0825</subfield><subfield code="h">412-420</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.398883 |